These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 16823924)

  • 1. Immunological evaluation of bacterial derived Cochleate and proteoliposome as mucosal adjuvants.
    del Campo J; Lastre M; Bracho G; Rodríguez T; Gil D; Zayas C; Taboada C; Acevedo R; Pérez DR; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-50-1. PubMed ID: 16823924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteliposome-derived Cochleate as an immunomodulator for nasal vaccine.
    Pérez O; Bracho G; Lastre M; Zayas C; González D; Gil D; del Campo J; Acevedo R; Taboada C; Rodríguez T; Fajardo ME; Sierra G; Campa C; Mora N; Barberá R; Solís RL
    Vaccine; 2006 Apr; 24 Suppl 2():S2-52-3. PubMed ID: 16823925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immunization using proteoliposome and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses.
    Campo JD; Zayas C; Romeu B; Acevedo R; González E; Bracho G; Cuello M; Cabrera O; Balboa J; Lastre M
    Methods; 2009 Dec; 49(4):301-8. PubMed ID: 19410000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel adjuvant based on a proteoliposome-derived cochleate structure containing native lipopolysaccharide as a pathogen-associated molecular pattern.
    Pérez O; Bracho G; Lastre M; Mora N; del Campo J; Gil D; Zayas C; Acevedo R; González D; López JA; Taboada C; Turtle C; Solis RL
    Immunol Cell Biol; 2004 Dec; 82(6):603-10. PubMed ID: 15550118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal and systemic immune responses of mice to tetanus toxoid coadministered nasally with AFCo1.
    Romeu B; González E; Del Campo J; Acevedo R; Zayas C; Valdés Y; Cabrera O; Cuello M; Balboa J; Lastre M; Pérez O
    Can J Microbiol; 2011 Mar; 57(3):256-61. PubMed ID: 21358768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The design of new adjuvants for mucosal immunity to Neisseria meningitidis B in nasally primed neonatal mice for adult immune response.
    Ferreira T; De Gaspari E
    ScientificWorldJournal; 2012; 2012():292073. PubMed ID: 22545012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteoliposome derived cochleate as novel adjuvant.
    Bracho G; Lastre M; del Campo J; Zayas C; González D; Gil D; Acevedo R; Taboada C; Solís RL; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-30-1. PubMed ID: 16823914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal immunization with purified flagellin from Salmonella induces systemic and mucosal immune responses in C3H/HeJ mice.
    Strindelius L; Filler M; Sjöholm I
    Vaccine; 2004 Sep; 22(27-28):3797-808. PubMed ID: 15315861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses.
    Romeu B; González E; Zayas C; Del Campo J; Acevedo R; Cuello M; Valdes Y; Balboa J; Cabrera O; Lastre M; Pérez O
    Scand J Infect Dis; 2011 Oct; 43(10):809-13. PubMed ID: 21671827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strategy for determination of an efficient Cochleate particle size.
    Gil D; Bracho G; Zayas C; del Campo J; Acevedo R; Toledo A; Lastre M; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-92-3. PubMed ID: 16823943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scale up of proteoliposome derived Cochleate production.
    Zayas C; Bracho G; Lastre M; González D; Gil D; Acevedo R; del Campo J; Taboada C; Solís RL; Barberá R; Pérez O
    Vaccine; 2006 Apr; 24 Suppl 2():S2-94-5. PubMed ID: 16823944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunization with Single Oral Dose of Alginate-Encapsulated BCG Elicits Effective and Long-Lasting Mucosal Immune Responses.
    Hosseini M; Dobakhti F; Pakzad SR; Ajdary S
    Scand J Immunol; 2015 Dec; 82(6):489-97. PubMed ID: 26286252
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pilot scale production of the vaccine adjuvant Proteoliposome derived Cochleates (AFCo1) from Neisseria meningitidis serogroup B.
    Zayas C; González D; Acevedo R; del Campo J; Lastre M; González E; Romeu B; Cuello M; Balboa J; Cabrera O; Guilherme L; Pérez O
    BMC Immunol; 2013; 14 Suppl 1(Suppl 1):S4. PubMed ID: 23458578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial derived proteoliposome for allergy vaccines.
    Lastre M; Pérez O; Labrada A; Bidot I; Pérez J; Bracho G; del Campo J; Pérez D; Facenda E; Zayas C; Rodríguez C; Sierra G
    Vaccine; 2006 Apr; 24 Suppl 2():S2-34-5. PubMed ID: 16823916
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intranasal immunization of mice with CpG DNA induces strong systemic and mucosal responses that are influenced by other mucosal adjuvants and antigen distribution.
    McCluskie MJ; Weeratna RD; Davis HL
    Mol Med; 2000 Oct; 6(10):867-77. PubMed ID: 11126201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel intranasal Protollin-based measles vaccine induces mucosal and systemic neutralizing antibody responses and cell-mediated immunity in mice.
    Chabot S; Brewer A; Lowell G; Plante M; Cyr S; Burt DS; Ward BJ
    Vaccine; 2005 Feb; 23(11):1374-83. PubMed ID: 15661386
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mucosal inoculation of Lactobacillus expressing hCGbeta induces an anti-hCGbeta antibody response in mice of different strains.
    Yao XY; Yuan MM; Li DJ
    Methods; 2006 Feb; 38(2):124-32. PubMed ID: 16414267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic immune responses induced by a single time vaccination strategy in mice.
    González Aznar E; Romeu B; Lastre M; Zayas C; Cuello M; Cabrera O; Valdez Y; Fariñas M; Pérez O
    Can J Microbiol; 2015 Aug; 61(8):531-8. PubMed ID: 26140382
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of systemic and mucosal antibody responses in mice immunized intranasally with aluminium-non-adsorbed diphtheria toxoid together with recombinant cholera toxin B subunit as an adjuvant.
    Isaka M; Yasuda Y; Kozuka S; Taniguchi T; Matano K; Maeyama J; Komiya T; Ohkuma K; Goto N; Tochikubo K
    Vaccine; 1999 Nov; 18(7-8):743-51. PubMed ID: 10547435
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.